IntelGenx Obtains Court-Approval of a Sale and Investment Solicitation Process marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.
IntelGenx has obtained an order from the Court approving the implementation of a sale and investment solicitation process intended to generate interest
IntelGenx Initiates Restructuring Proceedings Under the CCAA to Implement a Review of its Strategic Alternatives marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.
IntelGenx initiates restructuring proceedings - Canadian Manufacturing canadianmanufacturing.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from canadianmanufacturing.com Daily Mail and Mail on Sunday newspapers.
IntelGenx Technologies Corp. (OTCMKTS:IGXT) Short Interest Down 98.9% in April theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
IntelGenx Announces Voting Results on Election of Directors lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.
SAINT LAURENT, Quebec, April 08, 2024 -- IntelGenx Corp. today announced that Montelukast VersaFilm® has been administered to the first Parkinson’s Disease patients in the Phase 2 clinical...
IntelGenx Announces First Parkinson's Disease Patients Dosed with Montelukast VersaFilm® in Phase 2 ?MONTPARK' Clinical Trial lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.
SAINT LAURENT, Quebec, April 05, 2024 -- IntelGenx Corp. today announced that its co-developer, Chemo Research SL, through its agent and affiliate, Xiromed LLC , has received a Complete Response...
SAINT LAURENT, Quebec, March 11, 2024 -- IntelGenx Technologies Corp. announces that its wholly-owned subsidiary, IntelGenx Corp. , has entered into a third amended and restated loan agreement...